[在COVID-19疫情期间对间歇性肺病管理的专家共识]
概括
这份共识提供了15条建议,用于在患有先前存在的间歇性肺病 (ILD) 和后急性COVID-19 ILD (PC-ILD) 的患者中管理2019年冠状病毒病 (COVID-19). 它涉及诊断,治疗和监测,以改善患者的治疗结果.
科学领域:
- 肺部病理学 肺部病理学
- 传染性疾病 传染性疾病
- 关键护理医学 关键护理医学
背景情况:
- 预先存在的间歇性肺病 (ILD) 与2019年新冠病毒病 (COVID-19) 的严重程度和死亡率增加有关.
- 关于患有先前存在的ILD和后急性COVID-19ILD (PC-ILD) 的COVID-19患者的管理知识有限.
- 对于这些患者群体的治疗策略,需要专家共识是显而易见的.
研究的目的:
- 建立关于在患有先前存在的ILD的患者中诊断和管理COVID-19的共识.
- 为管理PC-ILD提供指导.
- 为了解决治疗这些患者的医生所面临的22个实际问题.
主要方法:
- 一个专家工作组建立了一个基于科学证据和临床经验的共识.
- 达成共识包括阐明实际问题和制定建议.
- 为诊断和管理制定了15个不同的建议.
主要成果:
- 建议涵盖COVID-19与ILD的区别,疾病严重程度的定义和管理策略.
- 提供了关于抗病毒治疗,全身皮质类固醇和向治疗 (例如IL-6受体抑制剂,JAK抑制剂) 的指导.
- 建议涉及免疫抑制剂,抗纤维菌药物,同时感染的管理,抗凝血,随访,康复和疫苗接种.
结论:
- 这一共识旨在帮助医生做出明智的决策,在患有ILD的患者中管理COVID-19.
- 它为先前存在的ILD和PC-ILD提供了实际指导.
- 这些建议旨在改善这些复杂的患者群体的临床结果.
相关概念视频
01:28Pleural Effusion II: Symptoms and Management
183
Pleural Effusion Overview
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
A pleural effusion is the abnormal collection of fluid between the parietal and visceral pleura layers of tissue that form the lining of the lungs and chest cavity. It can occur independently or due to surrounding parenchymal diseases, such as infection, malignancy, or inflammatory conditions.
Clinical Manifestations:
183
01:29Chronic Obstructive Pulmonary Disease-V: Management
2.5K
Managing Chronic Obstructive Pulmonary Disease (COPD) involves a multifaceted approach to reduce symptoms, prevent exacerbations, improve overall health status, and slow disease progression. Key strategies include lifestyle modifications, pharmacotherapy, supportive therapies, and, in some cases, surgery. Here is an overview of the primary COPD management strategies:
Smoking Cessation
Smoking Cessation
2.5K
01:28Pneumonia IV: Management
333
The treatment of pneumonia varies based on its severity and the causative pathogen. Here is a structured approach to managing pneumonia, integrating pharmaceutical and supportive care strategies.
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
Bacterial Pneumonia Treatment
For bacterial pneumonia, antibiotics serve as the cornerstone of therapy. Initial treatment often begins with empirical antibiotics, tailored to the anticipated causative organism and adjusted based on culture results. Key antibiotic choices include:
333
01:30Pneumonia V: Nursing management and Prevention
2.1K
Nursing management of pneumonia involves promoting airway patency, facilitating rest and conserving energy, encouraging fluid intake, maintaining nutrition, and educating patients.
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
The nurse must practice strict medical asepsis and adhere to infection control guidelines to minimize healthcare-associated infections.
Enhance airway patency
Position the patient correctly to facilitate drainage of the affected lung segments. Manual or mechanical percussion and vibration can also be employed....
2.1K
01:26COPD: Management Using Bronchodilators and Corticosteroids
214
Chronic obstructive pulmonary isease (COPD) involves a group of progressive lung disorders characterized by persistent airflow limitation and chronic respiratory symptoms. Asthma-COPD Overlap Syndrome (ACOS), encompassing features of both asthma and Chronic obstructive pulmonary disease (COPD), is a group of progressive lung disorders that includes chronic bronchitis, emphysema, and refractory (non-reversible) asthma. ACOS leads to complex clinical presentations that combine the inflammatory...
214
01:20Chronic Obstructive Pulmonary Disease-I: Introduction
2.8K
Chronic Obstructive Pulmonary Disease (COPD) is a long-lasting respiratory condition requiring continuous attention and care. It is a progressive lung disease that leads to breathing challenges due to airflow obstruction. It manifests as persistent respiratory symptoms and restricted airflow resulting from abnormalities in the airways and alveoli, usually due to long-term exposure to harmful particles or gases. COPD mainly consists of two primary conditions: emphysema and chronic bronchitis.
2.8K